Physician profile
Juan E Escobar
NPI 1548371933
$1,106.40
in general payments reported to CMS, 2019-2025
8 companies · $247 in 2025
The $247 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2021: $19.67 · 2023: $165 · 2024: $441 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $346.07 | 2019-2025 | Puraply Wound Matrix |
| Kerecis Limited | $167.54 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Avita Medical Americas, LLC | $146.32 | 2023 | Recell |
| Abbvie INC. | $145.29 | 2023-2025 | |
| Becton, Dickinson and Company | $97.52 | 2024 | Arista Ah Flexitip |
| Acera Surgical, INC. | $90.35 | 2024 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $68.68 | 2019-2025 | Grafix, Grafix Pl |
| Allergan, INC. | $44.63 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Escobar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.